Global Cord Blood
CORBF
$0.71
Share price
29.09%
Change (1 day)
-52.67%
Change (1 year)
Categories
Global Cord Blood (CORBF) - Cash on Hand
Cash on Hand as of March 2022 : $1.05 Billion USD
According to Global Cord Blood's latest financial reports the company has $1.05 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Global Cord Blood - Cash on Hand chart (from 2007 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | $1.05 B | 13.3% |
| 2021-03-31 | $0.92 B | 19.99% |
| 2020-03-31 | $0.77 B | 3.79% |
| 2019-03-31 | $0.74 B | 10.07% |
| 2018-03-31 | $0.67 B | 32.62% |
| 2017-03-31 | $0.51 B | 9.2% |
| 2016-03-31 | $0.46 B | 18.27% |
| 2015-03-31 | $0.39 B | 30.23% |
| 2014-03-31 | $0.30 B | 26.2% |
| 2013-03-31 | $0.24 B | 90.41% |
| 2012-03-31 | $0.12 B | 34.94% |
| 2011-03-31 | $93.54 M | 127.06% |
| 2010-03-31 | $41.19 M | |
| 2008-12-31 | $28.9 M | 5856.86% |
| 2007-12-31 | $0.48 M | -47.21% |
| 2006-12-31 | $0.91 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Cryo-Cell CCEL | $3.47 M | -99.67% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.35 B | -65.92% | 🇺🇸 USA |
 RadNet RDNT | $0.71 B | -31.74% | 🇺🇸 USA |
 National Healthcare
NHC | $0.24 B | -76.86% | 🇺🇸 USA |